Ortho-ATI® trademark in the USA
Hello,
Strengthening and expanding the intellectual property (IP) footprint of our products at Orthocell is paramount, particularly as we enter some of the largest and most influential healthcare markets in the world.
Today, I am pleased to inform you that we have been awarded United States Divisional Trade Mark Registration for our Ortho-ATI® cell therapy for the treatment of chronic tendon injuries. The trade mark application has been accepted and was registered in June 2020 under number 6,082,605. This will remain in force for an initial period of 10 years and may be renewed for successive periods of 10 years thereafter.
We are delighted to receive this important trade mark within the United States, which complements our strong intellectual property portfolio and our ongoing efforts to bring this exciting technology into the US market.
This news from OCC just appeared in my email ,
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
-0.015(1.19%) |
Mkt cap ! $302.9M | |||
| Open | High | Low | Value | Volume |
| $1.24 | $1.25 | $1.21 | $605.7K | 493.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16000 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| OCC (ASX) Chart |